Skip to main content
Journal of the Egyptian National Cancer Institute

Table 4 Comparison of OCT3/4 expression at diagnosis, remission, and relapse among leukemic patients

From: Significance of OCT3/4 and SOX2 antigens expression by leukemic blast cells in adult acute leukemia

Parameter

ALL (n = 38)

AML (n = 42)

Median (min–max)

Median (min–max)

OCT3/4 % at diagnosis

1.35 (0.1–35.3)

1.7 (0.1–14.0)

OCT3/4 % at remission

0.46 (0.02–2.1)

0.30 (0.02–1.0)

OCT3/4 %at relapse

1.31 (0.3–10.5)

2.15 (1.4-49.6)

P1

< 0.001

< 0.001

P2

0.515

0.475

P3

0.008

0.005

  1. Wilcoxon test, P1 between OCT3/4 level at diagnosis and remission in each group, P2 between OCT3/4 level at diagnosis and at relapse in each group, P3 between OCT3/4 level at remission and at relapse in each group
Back to article page